• Publications
  • Influence
Treatment of Kaposi's sarcoma—an update
Kaposi's sarcoma (KS) is an angioproliferative disease of multifactorial origin arising in different clinic-epidemiologic forms, which show the same histopathological features. It generally starts asExpand
  • 32
  • 2
[HIV protease inhibitors for the treatment of Kaposi's sarcoma].
A reduced incidence or the regression of Kaposi's sarcoma (KS) has been described in HIV-infected patients treated with HIV-protease inhibitors (PI). We have recently demonstrated that PI block theExpand
  • 3
Urothelial neoplasms and tumoral markers
The majority of urothelial neoplasms are superficial bladder carcinoma, the prognosis of which cannot be evaluated with current parameters. Several studies have tried to isolate one or more reliableExpand
Tumour markers in renal cell carcinoma. Literature review
The authors evaluated whether tumour markers can be considered useful in prognosis and therapeutical planning of renal cell carcinoma. This review has focused on those cytochemical and laboratoryExpand